Roche to cut jobs after setbacks for drugs
Health / Medicine Related News
Roche confirmed speculation about significant job cuts to tailor its spending to tougher market conditions, but said it would not give details until later this year
Source: FT.com - Pharmaceuticals
Roche To Buy US Biotech Firm InterMune For $8.3B
Biotechnology News
BERLIN (AP) ? Swiss pharmaceutical company Roche said Sunday it has reached an $8.3 billion deal to buy InterMune Inc., a California-based developer of treatments for lung diseases.
Source
Roche Biotech Unit Submits Skin Cancer Drug Application To U.S. Regulator
Biotechnology News
ZURICH (Reuters) - Genentech, U.S. biotech unit of Swiss drugmaker Roche holding, said on Monday it had filed a marketing application to U.S. regulators for the use of its experimental drug in combination with another medicine to treat an advanced form of skin cancer. Cobimetinib is designed to be used with another Roche drug called Zelboraf for patients with tumors that have a mutation in a gene known as BRAF that allows melanoma cells to grow. ...
Source